THIS BRIEF REVIEW WILL SUMMARIZE some recent insights into thin filament regulation of cardiac muscle contraction and relaxation. Several mutations in regulatory proteins of the thin filament have been described that change the regulation of contraction and relaxation, and, recently, their impact on in vivo and in vitro contractility was studied. Within the framework of current knowledge, we will also offer some suggestions for directions for further research.
REGULATION OF CONTRACTION BY THIN FILAMENT PROTEINS
Contraction of vertebrate striated (skeletal and cardiac) muscle is activated by the binding of Ca 2ϩ to the Ca 2ϩ -binding subunit troponin C (TnC) of the troponin complex, which, together with troponin I (TnI), troponin T (TnT), and tropomyosin (Tm), forms the regulatory system of the contractile apparatus (21, 72, 79, 96) . Contraction occurs when the myosin head in the thick filament interacts with actin in the thin filament causing the two filaments to slide past each other. The troponin complex in the thin filament regulates the actin-myosin interaction. Figure 1 summarizes the changes in the thin filament during activation of contraction. In the absence of Ca 2ϩ , the troponin complex exists in a closely held conformation. TnI inhibits actin-myosin binding by interacting with actin-Tm and fixing the troponin complex on actin through TnI's interaction with TnT (14, 15, 26, 68) . This inhibitory interaction of TnI with actin is completely eliminated when Ca 2ϩ binds to the amino-terminal Ca 2ϩ -specific sites (only site II in cardiac muscle) of TnC and the carboxyl terminus of TnI dissociates from the actin-Tm complex, which is then followed by the movement of Tm into a nonblocking position, allowing myosin to bind to actin (15, 26, 68) . The exact function of TnT is still somewhat controversial, but it is thought to stabilize the troponin complex and to affect the Ca 2ϩ sensitivity of actomyosin ATPase activity and the level of ATPase activation and/or force development (23, 44, 66, 68) . The extended amino acid terminus of TnT may interact with actin and with the overlapping regions of adjacent Tm molecules (28) . TnC, an EF-hand protein, transfers the Ca 2ϩ signal, eliciting contraction to the fiber, whereas the main function of TnI is to inhibit the actomyosin ATPase activity (40). TnT directly interacts with Tm (66), TnI (66) , and TnC (68) . Conformational changes in TnC affected by Ca 2ϩ binding (reviewed in Ref. 16 ) ultimately evoke the interactions between the thin filament proteins. In addition, TnI interaction with the other troponin subunits is affected by TnI phosphorylation (1, 32, 62) and by the oxidation state of Cys48 and Cys64 at the carboxyl terminus of TnI when interacting with TnT (9) .
MUTATIONS OF THIN FILAMENT PROTEINS IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease, characterized by left ventricular hypertrophy, myofibril disarray, and sudden cardiac death (SCD). Numerous studies have shown that FHC is caused by one of many missense or deletion mutations in various genes that encode for ␤-myosin heavy chain (3, 13, 20, 24, 92, 93) , ventricular myosin light chains 1 and 2 (12, 17, 67) , myosin binding protein C (88) , titin (75) , actin (50, 65) , ␣-Tm (10, 33, 57, 59, 71, 84, 87, 90) , TnT (2, 11, 36, 43, 51, 84-86, 89, 90) , and TnI (34, 37, 55, 77) . Whereas individuals with ␤-myosin heavy chain mutations, in general, have a higher level of cardiac hypertrophy, those with TnT mutations have less hypertrophy but a higher incidence of SCD in young adults (90) . To date, 15 human cardiac TnT mutations have been associated with FHC: I79N, R92Q/W/L, R94L, A104V, F110I, R130C, ⌬E160, E163K/R, S179F, E244D, R278C, and a mutation that arises from abnormal splicing of intron 16 (G 1 3 A) (2, 18, 27, 36, 51, 58, 84, 86, 90, 91) . Other mutations associated with FHC found in thin filament proteins are the cardiac Tm mutations A63V, K70T, V95A, D175N, and E180G/V (10, 33, 57, 59, 71, 84, 87, 90) ; the TnI mutations R145G/Q, R162W, ⌬K183, S199N, G203S, K206Q (34, 37), and an exon 8 deletion mutant (55) ; and four missense mutations in actin (50, 65) . Table 1 summarizes the clinical manifestations of each of these mutations in ␣-Tm, actin, TnI, and TnT. The mechanism by which these mutations alter cardiac contraction and relaxation is still largely unknown, although some studies suggest that changes in myofibrillar Ca 2ϩ sensitivity can lead to diastolic dysfunction and sensitivity to dysrhythmias, which at times cause sudden death. Tables 2 and 3 summarize the results from in vitro studies and from studies on transgenic animals, respectively, that examine the mechanisms of these mutations and pathologies associated with FHC. We will now highlight several key observations that relate to the mechanisms of FHC, in particular those caused by TnT mutations.
TnT. Several mutations in TnT are responsible for mechanical abnormalities in the sarcomeric complex. Replication-defective recombinant adenovirus vectors for gene transfer of I79N and R92Q mutant cardiac TnT cDNAs into fully differentiated adult cardiac cells in primary culture show a regular periodic pattern of immunolabeled TnT localization (74) . In this system, unlike others mentioned below, direct force measurements demonstrated marked desensitization of submaximal Ca 2ϩ -activated tension (74) . It was suggested that the decrease in Ca 2ϩ sensitivity may be attributed to a change in the secondary structure caused by the mutation of the incorporated protein (85) and that this Fig. 1 . Schematic diagram of the regulation of muscle contraction by troponin. TnC, TnI, and TnT, tropomyosin C, I, and T, respectively. N, amino terminus; C, carboxyl terminus (78a).
change in structure could subsequently modify the actin-Tm interaction of the myofibril (28) .
The TnT mutation in the intron 16 splice donor site is associated with pronounced left ventricular thickening and a high risk of sudden death (56, 91) . A glycine to alanine mutation in the intron 16 splice donor site of TnT was identified in all affected and three clinically unaffected adults of a family with a history of FHC (56) . The carboxyl terminus of TnT interacts with both TnC and TnI, and, predictably, these truncated proteins have a lower affinity for TnI (56) and, when reconstituted in a troponin complex, for actin-Tm (85) . This change in the affinity of the truncated TnTs for particular proteins or filament complexes may account for the inadequate regulatory function. Transgenic mice expressing low levels of truncated TnT (ϳ5%) have myocyte disarray, atrial hypertrophy, reduced ventricular mass, and overall fewer and smaller cardiomyocytes (resulting in a smaller heart) than their wild-type litter mates, whereas homozygous mice (twice the expression of truncated TnT) died within 24 h of birth (81) . The surviving transgenic mice showed diastolic dysfunction and cardiac arrhythmias postexercise consistent with impaired contractility.
Some TnT mutations cause an increase in unloaded myofilament sliding speed indicative of defective actomyosin cross-bridge activity and an increased or decreased Ca 2ϩ affinity (85) . A faster myofilament sliding speed was observed for I79N (42), R92Q (78), E244D, and the intron 16 (G 1 3 A) truncated TnT mutant, whereas ⌬E160 appears to decrease unloaded sliding speed of the filament (85) . The shift in sliding speed of the I79N, R92Q, and ⌬E160 TnT mutants is also accompanied by changes in Ca 2ϩ sensitivity of force or ATPase activity (reviewed in Ref. 85) .
The TnT-I79N mutation is of special interest because it poses the highest risk of SCD in young adults (90) . At present, there is no clear understanding of why this TnT-I79N mutation is associated with increased SCD. Several investigators have demonstrated an in vitro effect of the TnT-I79N mutation on the contractile properties of cardiac and skeletal muscle with conflicting results. Lin et al. (42), using rat cardiac TnT containing a mutation in an equivalent position to the TnT-I79N mutation in humans, showed that this mutant TnT had a normal affinity for actin-Tm and conferred normal Ca 2ϩ sensitivity to actomyosin ATPase activity. The regulated thin filaments, however, moved 50% faster over heavy meromyosin (HMM) than control filaments in an in vitro motility assay. Additional measurements utilizing the same system revealed that HMM exerted reduced isometric force on single thin filaments reconstituted with the TnT-I79N mutant (28). Sweeney et al. (78) reported that TnT-I79N transfected quail skeletal muscle myotubules had decreased Ca 2ϩ sensitivity of force production, whereas the unloaded shortening velocity was increased by about twofold. An embryonic isoform of rat TnT-I79N expressed in adult rat cardiac myocytes induced a decreased Ca 2ϩ sensitivity of isometric force (74) . Our results on TnT-I79N reconstituted porcine fibers (79) are in accord with Morimoto et al. (54) , who demonstrated that TnT-I79N reconstituted skinned rabbit trabeculae increased the Ca 2ϩ sensitivity of contraction. A recent study confirmed increased Ca 2ϩ sensitivity of myofibrillar ATPase activity of TnT-I79N reconstituted rabbit cardiac myofibrils (95) . Part of the disparity is likely due to the different in vitro assays used by these investigators, illustrating the need to study the effect of the mutations in an in vivo system. Until now, a transgenic model for the TnT-I79N has not been reported, although other mutant TnT transgenic mice have been described (Table 3) . Miller et al.
(49) examined a wild-type (Tg-WT) and two I79N-transgenic mouse lines (Tg-I79N) of human cardiac TnT (hcTnT) driven by a murine ␣-myosin heavy chain promoter. The levels of expression of either Tg-WT or Tg-I79N, relative to mouse cTnT, were 71% (WT) or 35% and 52% in the two I79N lines. Extensive characterization of the Tg-I79N lines compared with Tg-WT and/or non-Tg mice demonstrated the following: normal survival and no cardiac hypertrophy even with chronic exercise in all groups, large increases in the Ca 2ϩ sensitivity of ATPase activity and force in skinned fibers, a substantial increase in the rate of force activation and a small increase in the rate of force relaxation in flash photolysis experiments, significantly lower maximal force/cross-sectional area and ATPase activity, and a loss of sensitivity to pH-induced shifts in the Ca 2ϩ dependence of force correlated with hcTnT-I79N expression levels (49).
When native TnT is replaced with mutant I79N TnT, an increased filament speed is not unexpected. Alterations in the actin interaction surface may allosterically change actomyosin binding and cross-bridge kinetics. If changes in actomyosin interactions increase the rate of cross-bridge dissociation from actin, peak isometric force will be reduced and maximal filament sliding velocity increases. The increased Ca 2ϩ sensitivity of force in reconstituted skinned cardiac fibers in which native TnT was replaced with TnT-I79N (79) and in skinned cardiac fibers of transgenic mice (49) is not readily explained by changes in cross-bridge kinetics alone. The results from skinned cardiac fiber studies, flash photolysis force transients, and force-pCa relations (49) (Ca 2ϩ -specific site II) on force (29, 38) . Simulations postulate that an increase in the apparent rate of actomyosin cross-bridge detachment (g) was not sufficient to account for all experimental observations. The combination of an increased affinity of TnC for Ca 2ϩ and an increase in g reproduced all experimental observations in skinned fibers that contain the human TnT-I79N. An increased g was also inferred by others from their in vitro motility assays (28, 42) or TnT-I79N transfected myotubes (28) , and a consistent picture regarding this mutation is emerging based on results from several different approaches. Moreover, the crossbridge effects brought about by this mutation are distinct from the calcium effects, and it is possible that the former arise from an alteration in the interactions between TnT, Tm, and actin, whereas the latter arise from altered TnT and TnC interactions. The predicted increased affinity of TnC for Ca 2ϩ still requires experimental verification.
Compared with wild-type TnT, relaxation of force in TnT-I79N containing myocardium is slowed by a decreased affinity of TnC for Ca 2ϩ ; however, this effect is somewhat attenuated by an increase in g. The twitch contraction operates from a pCa range of ϳ7.7 at rest to a peak systolic value of 5.7. With the use of these pCa values, simulated peak twitch force in steady-state conditions in fibers containing Tg-I79N was shown to be higher than in fibers that contained Tg-WT (Fig. 2) . Simulations for intact living myocardium further predict a faster rise of force, a slower isometric relaxation, and an increased residual force or resting tension at the onset of the next contraction. If twitch amplitudes in both Tg-WT and Tg-I79N are the same or are normalized, isometric relaxation of Tg-I79N myocardium is slower than in the WT, as observed in isovolumetrically contracting isolated heart (Fig. 2) (35) . The higher basal contractile state, the increased rate of contraction, and the slower relaxation (35) in TnT-I79N myocardium would have the following consequences. First, the contractile reserve is decreased, and an increase in heart rate and/or of contractility, such as after isopro-terenol administration, would jeopardize relaxation and cause diastolic dysfunction. An increased contractility and heart rate would increase diastolic intracellular Ca 2ϩ concentration, cause intracellular Ca 2ϩ overload, and dysrhythmias. These predictions seem to hold true for Tg-I79N mice challenged with isoproterenol (35), which demonstrated an impaired inotropic response, relaxation impairment, and fatal dysrhythmias. It is likely that these mechanisms contribute to the mortality observed in patients with a TnT-I79N-based FHC, especially in stimulated states of contractility such as seen during vigorous exercise or during inotropic interventions. The E244D mutation of TnT also appears to increase Ca 2ϩ sensitivity (61) . The TnT-E244D mutation has a shorter side chain due to the absence of a methyl group in the aspartic acid residue, yet the charge is conserved. The spatial difference due to the lack of a methyl group becomes significant if it 1) alters TnT secondary structure, 2) alters protein-protein interaction within the troponin complex, 3) induces or eliminates structural changes in the troponin complex required for its regulatory properties, or 4) produces other effects. At least one of these conditions appears to have an impact on thin filament regulation. Skinned cardiac fiber reconstituted with the E244D TnT increased the maximum force and increased the Ca 2ϩ sensitivity of the force generated compared with wildtype TnT (61) . The E244D mutation is located in a region of the carboxyl terminus of TnT that interacts with Tm, and changes in TnT-Tm interaction may alter actomyosin regulation. Indeed, the E224D mutation was found to have a lower affinity for actin-Tm than wild-type TnT (85) . This mutation has been found in affected individuals of families with FHC having poor prognosis (90) .
The F110I TnT mutation is associated with variable cardiac morphologies and prognosis (2, 36, 43, 90) . This mutation, located in a region of TnT that interacts with actin and Tm (16), also increased the maximum force in skinned muscle fibers but did not influence the Ca 2ϩ sensitivity of force generation (61) .
Another TnT transgenic animal model reported by Oberst et al. (63) was generated for the human cardiac TnT-R92Q mutation using a murine cTnT promoter. The level of expression in transgenic lines (wild-type and R92Q) varied from 1 to 10% of the total cTnT pool. Diastolic dysfunction and myocyte disarray were observed in the mutant mice but not in wild-type mice (63) . The same TnT-R92Q mutant was expressed in transgenic mice, in which the level of R92Q expression varied from 30 to 92% (82) . A murine cTnT cDNA and a rat ␣-myosin heavy chain promoter were used in the latter study. The R92Q hearts had a significant induction of atrial natriuretic factor and ␤-myosin heavy chain transcripts, interstitial fibrosis, and mitochondrial pathology. Isolated cardiac myocytes from these R92Q transgenic mice had increased basal sarcomeric activation, impaired relaxation, and shorter sarcomere lengths. Isolated working hearts showed hypercontractility and diastolic dysfunction, both of which are common findings in patients with FHC (82) . Transgenic mice expressing 30%, 67%, and 92% R92Q TnT show a dose-related induction and progression of atrial hypertrophy but a constant and age-independent decrease in ventricular mass. Analogous to the cardiomyocytes and hearts of the truncated TnT transgenic mice (above), the R92Q myocytes and hearts are smaller than their wild-type counterparts. The left ventricle contains both hypertrophied and dying myocytes with abnormal histopathologies, which are particularly prevalent in the higher expressing mice (82) . The mice expressing 67% R92Q displayed higher heart rates and diastolic dysfunction, prolonged contraction and relaxation, and possible early activation of ATPase activity. The diastolic dysfunction is attributed to an increase in Ca It is reasonable to assume that a change to a more polar amino acid residue in the Tm-interacting domain of TnT will affect troponin interactions as shown by a reduction of the stability of troponin complex formation containing R92Q (74, 79) . In a recent paper (41), a murine ␣-myosin heavy chain promoter was used to produce a transgenic mouse expressing human cardiac TnT-R92Q. The level of protein expression was relatively low, and the mutant mice demonstrated myocyte disarray and excess interstitial collagen. Interestingly, none of these transgenic mice demonstrated significant cardiac hypertrophy. Exchange studies of TnT-R278C vastly increased Ca 2ϩ sensitivity, more than any other TnT mutation known hitherto (53, 79) . Reconstituted skinned cardiac fibers containing the R278C mutation in the globular carboxyl terminal domain of TnT greatly increases the Ca 2ϩ sensitivity of force development (79) . TnT residues 188-288, characterized as the T2 proteolytic fragment having an unusually large number of positively charged residues, have been reported to interact with Tm, TnI, and TnC (reviewed in Refs. 16 and 70) . The interaction of the TnT carboxyl terminus with Tm appears to be Ca 2ϩ dependent (76) . Mutation of a basic amino acid to a neutral in the carboxyl end of TnT may induce steric changes within the troponin complex, altering the contacts between the regulatory subunits in response to Ca 2ϩ . Ohtsuki's group (53) showed that this TnT mutation induced a higher level of sub-halfmaximum force as a result of a decrease in maximum force and cooperativity, although only a slight increase in Ca 2ϩ sensitivity was observed. TnI. The R145G TnI mutation identified in patients with FHC constitutes a change in charge in an evolutionarily conserved residue (34). We observed impairment in both ATPase assays and in the relaxation of force in skinned cardiac muscle preparations incorporating the R145G mutation (Lang R, Zhao J, Housmans PR, and Potter JD, unpublished observations). Another group reported that actin-Tm-activated myosin S1 ATPase assays using troponin complexes reconstituted with R145G TnI revealed no change in activation but induced minimal inhibition and increased the Ca 2ϩ sensitivity of regulation compared with wild-type TnI complexes (11) . The switch from a positively charged to a neutral residue in the R145G TnI mutation occurs in a region that interacts with the aminoterminal domain of TnC and possibly actin (reviewed in Ref. 16 ) and, consequentially, may alter the dynamics or influence the regulatory mechanism of the troponin complex. We detected a slight increase in the ␣-helical content in circular dichroism studies of the R145G mutant protein in addition to an increase in the affinity between TnC and R145G TnI in the presence of Ca 2ϩ and Mg 2ϩ vs. Mg 2ϩ alone (Lang R, Zhao J, Housmans PR, and Potter JD, unpublished observations). The large change in the ability of this mutant TnI to inhibit contraction, combined with the increased Ca 2ϩ sensitivity of contraction, would likely lead to severely impaired diastolic function.
␣-Tm. Six missense mutations in the cardiac ␣-Tm have been linked to FHC (Table 1 ). In vitro analysis of several missense mutations in the cardiac ␣-Tm gene have also shown increased Ca 2ϩ sensitivity (see Table  2 ). The A63V mutation, associated with poor prognosis and a risk of sudden death in individuals with FHC (59, 94) , was found to increase the Ca 2ϩ sensitivity of force production in the isometric force recordings of single adult rat myocytes that expressed this mutant ␣-Tm by means of an adenovirus vector (47). Three other mutations associated with FHC, K70T, E180G, and D175N, showed a smaller increase in Ca 2ϩ sensitivity of force production, with the smallest increase reported for the D175N mutation (4, 47). The D175N Tm mutation is associated with variable prognosis and pathophysiologies; however, favorable prognosis in some cases have been documented (10, 59, 87) . The D175N ␣-Tm mutation in transgenic mice causes impaired contractility and relaxation and enhances Ca 2ϩ sensitivity (57) . The increases in Ca 2ϩ sensitivity of force production, as reported by Michele et al. (47) (A63V Ͼ K70T Ͼ E180G Ͼ Ͼ D175N ϭ wild type), appear to be directly related to the severity of the disease. Several lines of transgenic mice overexpressing the D175N Tm mutation at Ͻ40% and 60% of total Tm myofibrillar content suggest that the degree of physiological abnormalities associated with the mutation is dependent on the amount of mutant ␣-Tm incorporated in the filaments (57) . Mice expressing 60% of the mutant protein had reduced contraction and relaxation rates during exercise compared with the mice expressing Ͻ40% of the D175N protein or compared with the wild-type littermates (57) . The abnormal cardiac performance of the D175N transgenic mice was attributed to an increase in Ca 2ϩ sensitivity, which was observed in skinned fiber preparations. Protein-protein interactions within the troponin-Tm complex may mediate the regulatory dysfunction because both D175N and E180G are within a region considered to interact with TnT, whereas A63V and K70T are in repeat sequences and may alter Tm-actin interaction (reviewed in Refs. 6, 16, 70) .
␣-Actin. In 1999, the first ␣-actin mutation linked to FHC was reported in a Danish family. The A295S ␣-actin mutation was found in 13 individuals with different disease phenotypes and a variable age of disease onset (as early as 4 yr old) (50) . Only one individual was asymptomatic, whereas 3 of the 13 with the mutation showed more severe phenotypes, which included pronounced hypertrophy, ventricular tachycardia, and diastolic dysfunction (50) . The only other report identifying cardiac actin mutations linked to FHC is a recent study describing the phenotypes of family members of three individuals with different actin mutations. In this study, two de novo mutations (P164A and A331P) were associated with early-onset (8 yr and 17 mo of age, respectively) left ventricular hypertrophy and repolarization abnormalities (65) . The third actin mutation, E99K, was found to be autosomal dominant, with affected individuals having a later onset of the disease, variable hypertrophy, and diastolic dysfunction (65) . FHC-linked mutations in other genes were excluded in both studies. The four missense cardiac actin mutations are located near or within regions that interact with other actin molecules, troponin components, or the myosin head and may either destabilize the sarcomeric structure or alter the force generation during the cross-bridge cycle of contraction. Defective myofilament regulation or function may be due to reduced or enhanced filament proteinprotein interaction caused by replacement of a neutral or acidic amino acid with a polar or basic amino acid (A295S and E99K missense mutations); a faulty actinactin interaction may affect calcium signal transduction by altering the Tn-Tm-actin interaction. A change in the secondary structure of actin, possibly induced by replacement or addition of the ␣-helical-destabilizing amino acid proline (as in the case of P164A and A331P), could also conceivably alter the native environment in actin that interacts with itself or other filament components and ultimately affect force generation and regulation. These cardiac actin mutations were only recently identified; therefore, little is known about their functional consequences.
SUMMARY AND CONCLUSIONS
Thin filament proteins provide for a very tight regulation of cardiac contraction and relaxation. Each of several mutations profoundly impacted basal contractility and the time course of relaxation. In most mutations, Ca 2ϩ sensitivity of force development was increased; in some cases, filament sliding velocity was also increased ( Table 2 ). The myofilament is a highly interacting system in which even a slight change in interaction between any of the filament components may alter the Ca 2ϩ sensitivity of force generation. TnT plays a key role in maintaining the Ca (49) . Impaired contractile function due to thin filament mutations would most likely contribute to the progression of compensatory hypertrophy (FHC).
Mutations in thin filament proteins give rise to varying degrees of hypertrophy and incidences of SCD (Table 1) . One of the most puzzling questions regarding the pathogenesis of TnT-related FHC is the mechanism of SCD. Individuals with TnT-related FHC tend to exhibit mild or no ventricular hypertrophy, yet experience a high frequency of sudden death at an early age. These events could result from diastolic dysfunction, from the lack of pH sensitivity of Ca 2ϩ sensitivity of force, from alterations in intracellular Ca 2ϩ homeostasis, and/or from other processes. It remains to be determined whether the occurrence of SCD results from an altered thin filament environment or whether additional primary affects of the point mutation act at the level of the cardiac myocyte. Future work in this area should provide insights into the molecular mechanisms responsible for the induction and progression of FHC.
